-
1
-
-
0020964823
-
Coronary heart disease and atrial fibrillation: The Framingham study
-
W.B. Kannel, R.D. Abbott, and D.D. Savage et al. Coronary heart disease and atrial fibrillation: the Framingham study Am Heart J 106 1983 389 396
-
(1983)
Am Heart J
, vol.106
, pp. 389-396
-
-
Kannel, W.B.1
Abbott, R.D.2
Savage, D.D.3
-
2
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
-
A.S. Go, E.M. Hylek, and K.A. Phillips et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
-
3
-
-
0034778819
-
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
-
S. Stewart, C.L. Hart, and D.J. Hole et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 2001 516 521
-
(2001)
Heart
, vol.86
, pp. 516-521
-
-
Stewart, S.1
Hart, C.L.2
Hole, D.J.3
-
4
-
-
0029984410
-
Management of patients with atrial fibrillation. A statement for healthcare professionals. from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
-
E.N. Prystowsky, D.W. Benson Jr., and V. Fuster et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association Circulation 93 1996 1262 1277
-
(1996)
Circulation
, vol.93
, pp. 1262-1277
-
-
Prystowsky, E.N.1
Benson, Jr.D.W.2
Fuster, V.3
-
5
-
-
77957699729
-
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
-
A.J. Camm, P. Kirchhof, and G.Y.H. Lip et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.H.3
-
6
-
-
79953038399
-
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
V. Fuster, L.E. Rydén, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e269 e367
-
(2011)
Circulation
, vol.123
-
-
Fuster, V.1
Rydén, L.E.2
Cannom, D.S.3
-
7
-
-
84856745317
-
Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
-
J.J. You, D.E. Singer, and P.A. Howard et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e531S e575S
-
(2012)
Chest
, vol.141
-
-
You, J.J.1
Singer, D.E.2
Howard, P.A.3
-
8
-
-
0035837496
-
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
-
A.L. Klein, R.A. Grimm, and R.D. Murray et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
-
(2001)
N Engl J Med
, vol.344
, pp. 1411-1420
-
-
Klein, A.L.1
Grimm, R.A.2
Murray, R.D.3
-
9
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
M.R. Patel, K.W. Mahaffey, and J. Garg et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
10
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
C.B. Granger, J.H. Alexander, and J.J. McMurray et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
11
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
S.J. Connolly, M.D. Ezekowitz, and S. Yusuf et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
-
12
-
-
78751637313
-
Dabigatran versus warfarin in patients with atrial fibrillation: An analysis of patients undergoing cardioversion
-
R. Nagarakanti, M.D. Ezekowitz, and J. Oldgren et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion Circulation 123 2011 131 136
-
(2011)
Circulation
, vol.123
, pp. 131-136
-
-
Nagarakanti, R.1
Ezekowitz, M.D.2
Oldgren, J.3
-
13
-
-
84877276344
-
Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial
-
J.P. Piccini, S.R. Stevens, and Y. Lokhnygina et al. Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial J Am Coll Cardiol 61 2013 1998 2006
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 1998-2006
-
-
Piccini, J.P.1
Stevens, S.R.2
Lokhnygina, Y.3
-
14
-
-
84893362981
-
Efficacy and safety of apixaban in patients following cardioversion for atrial fibrillation: Insights from the ARISTOTLE trial
-
[ePub]
-
G. Flaker, R.D. Lopes, and S.M. Al-Khatib et al. Efficacy and safety of apixaban in patients following cardioversion for atrial fibrillation: insights from the ARISTOTLE trial J Am Coll Cardiol 2013 [ePub]
-
(2013)
J Am Coll Cardiol
-
-
Flaker, G.1
Lopes, R.D.2
Al-Khatib, S.M.3
-
16
-
-
79951853372
-
-
Boehringer Ingelheim International Gmbh Last accessed November 18, 2013
-
Boehringer Ingelheim International GmbH Pradaxa (dabigatran etexilate) summary of product characteristics http://www.ema.europa.eu/docs/en-GB/document- library/EPAR-Product-Information/human/000829/WC500041059.pdf 2013 Last accessed November 18, 2013
-
(2013)
Pradaxa (Dabigatran Etexilate) Summary of Product Characteristics
-
-
-
18
-
-
23044505564
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
-
(2005)
J Thromb Haemost
, vol.3
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
19
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
|